MedPath

Web-based Cognitive Behavioral Treatment for Insomnia in Dementia Caregivers

Not Applicable
Recruiting
Conditions
Insomnia Chronic
Dementia
Interventions
Behavioral: Web-based Cognitive Behavior Therapy for Insomnia (CBT-I)
Registration Number
NCT04632628
Lead Sponsor
University of South Florida
Brief Summary

Over the next 30 years, more than 10 million persons living with dementia in the United States will receive care at home from an unpaid and untrained family caregiver. At home care is preferred by caregivers and persons with dementia alike, but increases the caregiver's risk of insomnia and related negative health outcomes, including depression, anxiety, cognitive disturbances and poor quality of life. Cognitive behavioral therapy for insomnia (CBT-I) is a highly effective and established evidence based treatment for adults of all ages. Although relatively understudied in dementia caregivers, the research by our group and others suggests CBT-I is also efficacious in caregivers. Our team developed a brief (4 session) CBT-I protocol specifically adapted for dementia caregivers (CBT-I) and has shown in person and remote (i.e. telehealth) delivery of this protocol significantly reduces insomnia symptoms and improves mood (moderate to large effects). Given demands on caregivers' time and limited availability of trained CBT-I providers, a web-based version of CBT-I (WebCBT-I; the online treatment will be called NiteCAPP) is needed to increase the accessibility of this efficacious treatment. WebCBT-I will allow for flexible at home scheduling, and the skills needed to monitor caregiver treatment progress can be quickly and efficiently taught to healthcare providers. The overarching goal of this project is to develop and test WebCBT-I in caregivers of persons with dementia.

Objectives

1. To examine the clinical and health characteristics, including sleep, pain, fatigue, cognitive abilities, and cardiovascular health in dementia caregivers with insomnia.

2. To examine changes in the primary clinical outcomes, including complaints of poor sleep, and fatigue.

3. To examine changes in the secondary clinical outcomes, including mood, daytime functioning, cognitive functioning, and cardiovascular health.

4. To examine the mechanistic variables, including arousal (heart rate variability, HRV).

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • 18+ yrs
  • Dementia caregiver living with person with dementia
  • willing to be randomized, 4. read/understand English
  • insomnia diagnosis
  • no prescribed or over-the-counter sleep meds or stabilized 6+ weeks.

Insomnia:

  • complaints for 6+ mos
  • adequate opportunity and circumstances for sleep
  • 1+ of the following: difficulty falling asleep, staying asleep, or waking too early
  • daytime dysfunction (mood, cognitive, social, occupational) due to insomnia
  • Screening interview indicates Insomnia Severity Index score ≥11 or Insomnia Severity Index score 9-10
  • baseline diaries indicate >30 mins of sleep onset latency or wake after sleep onset on 3+ nts.
Exclusion Criteria
  • unable to consent
  • cognitive impairment [Telephone Interview for Cognitive Status (TICS) <25 or Mini Mental State Examination (MMSE) <26]
  • sleep disorder other than insomnia [i.e., sleep apnea (apnea/hypopnea index, AHI >15)]
  • bipolar or seizure disorder
  • other major psychopathology except depression or anxiety (e.g., suicidal ideation/intent, psychosis)
  • severe untreated psychiatric comorbidity
  • psychotropic or other medications (e.g., beta-blockers) that alter sleep
  • non-pharmacological tx for sleep or mood outside current trial.

PERSONS WITH DEMENTIA

Inclusion Criteria:

  • 18+ yrs
  • Persons with dementia living with caregiver
  • Have an eligible caregiver
  • willing to be randomized

Exclusion Criteria:

• Person with dementia or legally authorized representative is unable to consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
NiteCAPP: Online Cognitive Behavioral Therapy for InsomniaWeb-based Cognitive Behavior Therapy for Insomnia (CBT-I)This is a pilot trial with one treatment condition (CBT-I).
Primary Outcome Measures
NameTimeMethod
Daily Electronic Sleep and Pain Diaries - Total Sleep Time6 weeks

Subjective total sleep time

Insomnia Severity Index6 weeks

Insomnia severity measurement; min: 0 max:28; higher score means greater insomnia severity

Daily Electronic Sleep and Pain Diaries - Medication Consumption6 weeks

Sleep and pain medication consumption

Daily Electronic Sleep and Pain Diaries - Sleep Onset Latency6 weeks

Subjective sleep onset latency (time to fall asleep)

Daily Electronic Sleep and Pain Diaries - Pain Intensity & Unpleasantness6 weeks

Pain Intensity \& Unpleasantness

Objective Daily Sleep Actiwatch-2 - Sleep Onset Latency6 weeks

Objective sleep onset latency (time to fall asleep)

Objective Daily Sleep Actiwatch-2 - Wake-time After Sleep Onset6 weeks

Objective time awake after sleep onset

Objective Daily Sleep Actiwatch-2 - Sleep Efficiency6 weeks

Objective sleep efficiency

Objective Daily Sleep Actiwatch-2 - Total Sleep Time6 weeks

Objective total sleep time

Daily Electronic Sleep and Pain Diaries - Wake-time After Sleep Onset6 weeks

Subjective time awake after sleep onset

Daily Electronic Sleep and Pain Diaries - Sleep Efficiency6 weeks

Subjective sleep efficiency

Secondary Outcome Measures
NameTimeMethod
Dysfunctional Attitudes/Beliefs about Sleep (DBAS)6 weeks

evaluates sleep-related beliefs, expectations and attitudes regarding the causes, consequences, and potential treatments of sleep issues - higher scores indicates more dysfunctional beliefs and attitudes

State Trait Anxiety Inventory (STAI-Y1)6 weeks

Assessment of anxiety symptoms - min: 0 max:60; higher score means higher anxiety

Beck Depression Inventory Second Edition (BDI- II)6 weeks

Depressive symptom assessment - min: 0 max: 63; Higher score means higher severity of depression

Perceived Stress Scale (PSS)6 weeks

Perception of stress - min: 0; max:40 - higher scores indicate higher perceived stress

Online Cognitive Assessment - Stroop6 weeks

Determine level of cognitive functioning

Zarit Burden Scale6 weeks

Caregiver burden measurement - min: 0 max: 48 - higher score indicated higher caregiver burden

Kingston Caregiver Stress Scale6 weeks

Caregiver stress measurement - min:10 max:50 - higher score indicates higher caregiver stress

Caregiver Functional Unit Scale6 weeks

Assessment of the stability of the patient-caregiver dyad - higher score indicates lower stability

Online Cognitive Assessment - Wisconsin Card Sorting Task6 weeks

Determine level of cognitive functioning

Online Cognitive Assessment - Sternberg6 weeks

Determine level of cognitive functioning

Cognitive Failures Questionnaire6 weeks

Self-reported failures in perception, memory, and motor function - min:0 max: 100 - higher score indicates greater cognitive failure

Dementia Patient's Caregiver Quality of Life Scale6 weeks

Assessment of caregiver quality of life - min: 0 max:100 - higher score indicates good quality of life

Trial Locations

Locations (1)

University of Missouri

🇺🇸

Columbia, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath